Abliva AB (publ)

(NEVPF)

By |

Profile

Abliva AB is a Swedish company which is active in pharmaceutical development. Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell's energy provider, the mitochondria, do not function properly. The portfolio includes projects at different stages and ranges from early discovery phase to clinical phase.

Contact Information

Website: www.abliva.com
Main Phone: +46 462756220
Address: Medicon Village
Address 2: Scheelevagen 2
City / Town: Lund
Country: SE
Postal Code: SE-22381

Issuer Information

Exchange: OTO
Employees: 9

Equities News

Profile

Abliva AB is a Swedish company which is active in pharmaceutical development. Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell's energy provider, the mitochondria, do not function properly. The portfolio includes projects at different stages and ranges from early discovery phase to clinical phase.

Contact Information

Website: www.abliva.com
Main Phone: +46 462756220
Address: Medicon Village
Address 2: Scheelevagen 2
City / Town: Lund
Country: SE
Postal Code: SE-22381

Issuer Information

Exchange: OTO
Employees: 9

Equities News

$ 0.098 $ -0.01275 (-11.51%)
Last Price 0.098 Change $ -0.01275 Change % -11.51 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.12 High 0.12 Low 0.098 Prev Close 0.11
Last Trade Volume 7,780 52 Wk Hi 0.19 52 Wk Low 0.06
Market Cap 29 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 296,340,132.00 EPS (TTM) N/A PE Ratio N/A Exchange OTCPK
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1.3 1.3 1.3 1.3
Low Target Price Estimate 1.3 1.3 1.3 1.3
Mean Target Price Estimate 1.3 1.3 1.3 1.3
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 12/05/16 12/05/16 12/05/16 12/05/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago